Hayward James A 4
4 · APPLIED DNA SCIENCES INC · Filed Aug 31, 2018
Insider Transaction Report
Form 4
Hayward James A
DirectorChairman, CEO and President10% Owner
Transactions
- Award
Stock Option (right to buy)
2018-07-10+666,667→ 666,667 totalExercise: $3.51From: 2018-07-10Exp: 2021-07-10→ Common Stock (666,667 underlying) - Disposition to Issuer
Stock Option (right to buy)
2018-07-10−666,667→ 0 totalExercise: $3.51Exp: 2018-07-10→ Common Stock (666,667 underlying) - Award
Stock Option (right to buy)
2018-08-29+250,000→ 250,000 totalExercise: $1.19From: 2018-08-29Exp: 2028-08-28→ Common Stock (250,000 underlying)
Footnotes (1)
- [F1]The two reported transactions involve an amendment of an outstanding option to extend the expiration date of such option from July 10, 2018 to July 10, 2021, resulting in the deemed cancellation of the "old" option and the grant of a replacement option. The option was originally granted on July 11, 2011 and provided for vesting (i) with respect to 25% of the underlying shares on the original date of grant and (ii) with respect to the remaining underlying shares, ratably each anniversary thereafter until fully vested on the second anniversary of the original date of grant.